• Home
  • Company Info
    • General Information
    • Nature of Business
    • Business Structure
    • Company Milestone
    • Message from Chairman
    • Organization Chart
    • Board of Directors
    • Sub-Committees
      • Audit Committee
      • Nomination and Remuneration Committee
      • Corporate Governance and Sustainable Development Committee
      • Risk Management Committee
    • Management Team
  • Financial Info
    • Financial Highlights
    • Financial Statements
    • Management Discussion and Analysis
  • Stock Info
    • Stock Quotes
    • Historical Price
    • Investment Calculator
  • Shareholder Info
    • Major Shareholders
    • Dividend Policy and Payment
    • Shareholders' Meeting
    • IR Calendar
    • Newly Issued Ordinary Shares
    • Warrant Information
  • Corporate Governance
    • Corporate Governance Policy
    • Charters
    • Whistleblowing Channel Form
  • Publications
    • Investor Kits
    • Prospectus
    • Annual Report / Form 56-1
    • CSR Gallery
    • Presentations and Webcast
  • Newsroom
    • SET Announcements
    • Press Releases
    • News Clippings
    • Videos
    • Analyst Research
    • Online News
    • Company Announcement
  • Information Inquiry
    • IR Contact
    • Email Alerts
  1. Home
  2. Newsroom
  3. SET Announcements

SET Announcements

Notification the exercise of IP-W2

01 December 2023
Read More

Notification of the Company's holiday for the year 2024

01 December 2023
Read More

Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023

14 November 2023
Read More

Financial Performance Quarter 3 (F45) (Reviewed)

14 November 2023
Read More

Financial Statement Quarter 3/2023 (Reviewed)

14 November 2023
Read More

Invitation for Shareholders to propose Agenda in advance for the 2024 Annual General Meeting, Candidates in the Election of the Company's Directors

31 October 2023
Read More

Report on the results of the Exercise of IP-W1 (F53-5)

06 October 2023
Read More

05 September 2023 is the last trading day of IP-W1

04 September 2023
Read More

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2023

10 August 2023
Read More

Financial Performance Quarter 2 (F45) (Reviewed)

10 August 2023
Read More

Financial Statement Quarter 2/2023 (Reviewed)

10 August 2023
Read More

Report on the Utilization of Capital Increased as at June 30th, 2023

26 July 2023
Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›

Follow Us

  • Home
  • Company Info
    • General Information
    • Nature of Business
    • Business Structure
    • Company Milestone
    • Message from Chairman
    • Organization Chart
    • Board of Directors
    • Sub-Committees
    • Management Team
  • Financial Info
    • Financial Highlights
    • Financial Statements
    • Management Discussion and Analysis
  • Stock Info
    • Stock Quotes
    • Historical Price
    • Investment Calculator
  • Shareholder Info
    • Major Shareholders
    • Dividend Policy and Payment
    • Shareholders' Meeting
    • IR Calendar
    • Newly Issued Ordinary Shares
    • Warrant Information
  • Corporate Governance
    • Corporate Governance Policy
    • Charters
    • Whistleblowing Channel Form
  • Publications
    • Investor Kits
    • Prospectus
    • Annual Report / Form 56-1
    • CSR Gallery
    • Presentations and Webcast
  • Newsroom
    • SET Announcements
    • Press Releases
    • News Clippings
    • Videos
    • Analyst Research
    • Online News
    • Company Announcement
  • Information Inquiry
    • IR Contact
    • Email Alerts

© Copyright - Interpharma Group

  • Sitemap
  • Terms and Conditions